Using PSMA imaging for prognostication in localized and advanced prostate cancer-Reference-Cited by-同舟云学术

Using PSMA imaging for prognostication in localized and advanced prostate cancer

Published:2022-12-06 Issue:1 Volume:20 Page:23-47
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Roberts Matthew J.^ORCID,Maurer Tobias^ORCID,Perera Marlon^ORCID,Eiber Matthias,Hope Thomas A.,Ost Piet^ORCID,Siva Shankar,Hofman Michael S.,Murphy Declan G.^ORCID,Emmett Louise,Fendler Wolfgang P.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://www.nature.com/articles/s41585-022-00670-6.pdf

Reference287 articles.

1. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

2. Mottet, N. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. EAU https://uroweb.org/guidelines/prostate-cancer (2020).

3. Wallitt, K. L. et al. Clinical PET imaging in prostate cancer. RadioGraphics 37, 1512–1536 (2017).

4. Jadvar, H. Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET. Nat. Rev. Urol. 6, 317–323 (2009).

5. Jadvar, H. Is there use for FDG-PET in prostate cancer? Semin. Nucl. Med. 46, 502–506 (2016).

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous targeting and monitoring of free antigen and in-situ membrane antigen in prostate cancer cells via an aggregation-induced emission-based bifunctional probe;Biosensors and Bioelectronics;2024-11

2. Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics;BJU International;2024-09-11

3. From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer;Cancers;2024-08-31

4. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

5. Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients;Cancers;2024-07-23